Deciphera Pharmaceuticals, Inc.
Deciphera Pharmaceuticals, Inc. (DCPH) SEC Filings & 10-K Annual Reports
SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.
SEC EDGAR · data.sec.gov · CIK 0001654151 · DCPH · NASDAQ · as of Jun 8, 2026
Filing snapshot
Source: SEC EDGAR (data.sec.gov) · CIK 0001654151 · Updated hourly · Not investment advice
Latest Annual Report
Latest Key Filings
Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.
SEC Filing History
About SEC Filings & 10-K Annual Reports
Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH) has submitted 580 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2017. As a Healthcare sector company with CIK 0001654151, all filings are publicly accessible via the EDGAR database at no cost.
The annual 10-K report is Deciphera Pharmaceuticals, Inc.'s most comprehensive regulatory disclosure. The most recent Deciphera Pharmaceuticals, Inc. 10-K was filed on 2024-02-07 for fiscal year ending 2024. Historical DCPH 10-K annual reports are available from 2015 through 2024.
Investors researching Deciphera Pharmaceuticals, Inc. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.
Frequently Asked Questions
DCPH SEC Filings · 8 questionsDeciphera Pharmaceuticals, Inc. (DCPH) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 580 filings and access original documents at no cost. Deciphera Pharmaceuticals, Inc.'s CIK is 0001654151.